pe cd44 Search Results


mouse  (Elabscience Biotechnology)
93
Elabscience Biotechnology mouse
Mouse, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/PE+Anti-Human%2FMouse+CD44+Antibody/pmc12234964-246-18-22
Average 93 stars, based on 1 article reviews
mouse - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
cd44 pe tonbo biosciences  (Cytek Biosciences)
93
Cytek Biosciences cd44 pe tonbo biosciences
Cd44 Pe Tonbo Biosciences, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/PE+Anti-Human%2FMouse+CD44/10__1096_slash_fj__202200919r-78-101-103
Average 93 stars, based on 1 article reviews
cd44 pe tonbo biosciences - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
cd44 antibody  (Elabscience Biotechnology)
93
Elabscience Biotechnology cd44 antibody
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Cd44 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/PE+Anti-Human+CD44+Antibody/pmc12254866-53-5-12
Average 93 stars, based on 1 article reviews
cd44 antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
mouse monoclonal anti cd44 antibody  (Cedarlane)
88
Cedarlane mouse monoclonal anti cd44 antibody
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Mouse Monoclonal Anti Cd44 Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/Anti-Mouse+CD44+%2C+PE+(Clone+IM7%2E8%2E1)+(rat+IgG2b)/pmc03397118-221-19-23
Average 88 stars, based on 1 article reviews
mouse monoclonal anti cd44 antibody - by Bioz Stars, 2026-09
88/100 stars
  Buy from Supplier
anti mouse cd44 antibody  (Cedarlane)
93
Cedarlane anti mouse cd44 antibody
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Anti Mouse Cd44 Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/Anti-Mouse+CD44%2C+PE+(Clone+KM81)+(rat+IgG2a)/pm33930309-479-9-12
Average 93 stars, based on 1 article reviews
anti mouse cd44 antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
pe conjugated cd44v6 monoclonal antibody  (R&D Systems)
91
R&D Systems pe conjugated cd44v6 monoclonal antibody
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Pe Conjugated Cd44v6 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/Human+CD44+v6+PE-conjugated+Antibody/10__1074_slash_jbc__m109__022418-111-21-30
Average 91 stars, based on 1 article reviews
pe conjugated cd44v6 monoclonal antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
pe conjugated cd44  (R&D Systems)
93
R&D Systems pe conjugated cd44
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Pe Conjugated Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/Human%2FMouse+CD44+PE-conjugated+Antibody/10__4103_slash_jasmr__jasmr_4_22-67-1-9
Average 93 stars, based on 1 article reviews
pe conjugated cd44 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
cd44 apc  (R&D Systems)
93
R&D Systems cd44 apc
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Cd44 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/Human+CD44+v6+PE-conjugated+Antibody/pm41631682-53-21-27
Average 93 stars, based on 1 article reviews
cd44 apc - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
nbp2 22530pe  (Novus Biologicals)
94
Novus Biologicals nbp2 22530pe
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Nbp2 22530pe, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/CD44+Antibody+(Hermes-1)+%5BPE%5D/pmc11083126-150-0-1
Average 94 stars, based on 1 article reviews
nbp2 22530pe - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
pe conjugated anti cd44  (Biorbyt)
91
Biorbyt pe conjugated anti cd44
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Pe Conjugated Anti Cd44, supplied by Biorbyt, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/CD44+antibody+(PE)/pm31200145-89-32-35
Average 91 stars, based on 1 article reviews
pe conjugated anti cd44 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
cd44v6 pe  (R&D Systems)
96
R&D Systems cd44v6 pe
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Cd44v6 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/CD44+Antibody+(CD44V6%2F9400R)+%5BPE%5D/pm35114411-60-32-36
Average 96 stars, based on 1 article reviews
cd44v6 pe - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
anti cd44  (Proteintech)
94
Proteintech anti cd44
Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of <t>CD44</t> + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.
Anti Cd44, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pe+cd44/PE+Anti-mouse+CD44/10__3727_slash_096504016x14772331883976-91-31-33
Average 94 stars, based on 1 article reviews
anti cd44 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of CD44 + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

doi: 10.1016/j.apsb.2025.04.006

Figure Lengend Snippet: Regulation of the stem-property in 4T1 cells. (A) Transwell analysis in 4T1 cells, scale bars = 200 μm; (B, C) The representative images of scratch assay in 4T1 cells and the statistical analysis of wound area, scale bar = 100 μm; (D) Representative images of the 4T1 tumorspheres on Day 12 after different treatments, scale bar = 50 μm; (E, F) The statistical analysis of number and diameter of tumorspheres; (G) Schematic mechanism of SHK inhibiting stem-property of 4T1 cells; (H) Western blot analysis of PKM2, β -Catenin, epithelial or mesenchymal markers, stem-property markers in 4T1 cells; Quantization of Western blot analysis (I) and the mRNA levels (J) of β- catenin, Pkm2, Vimentin, Oct4, Sox2, Nanog and E-cadherin in 4T1 cells; (K, L) The population of CD44 + /CD24 ‒ subtype in drug treated 4T1 cells and statistical analysis. Data are presented as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.

Article Snippet: MHC II antibody, CD206 antibody, CD44 antibody, CD24 antibody were purchased from Elabscience (Wuhan, China).

Techniques: Wound Healing Assay, Western Blot

In vivo therapeutic efficacy of nanoparticles in a mouse model with orthotopic breast cancer. (A) Therapeutic schedule; (B) The tumor image, (C) tumor volume curves and (D) tumor weight, (E) Body weight curves; (F) Statistical analysis of body weight on the last day during treatment; (G) The ratio of the M1-like TAM (F4/80 + CD86 + ) subset; (H) The ratio of the M2-like TAM (F4/80 + CD206 + ) subset; (I) The ratio of the matured DC (CD80 + CD86 + ) subset; (J) The ratio of the PMN-MDSC (Ly6G + Ly6C − ) subset; (K) The ratio of the memory T cells (CD62L + CD44 + ) subset; (L) The ratio of the CD8 + T cells (CD3 + CD8 + ) subset; (M, N) The ratio of the cytotoxicity CD8 + T cells (IFN γ + /Granzyme B + ) subset. Data are presented as mean ± SD ( n = 3–6). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

doi: 10.1016/j.apsb.2025.04.006

Figure Lengend Snippet: In vivo therapeutic efficacy of nanoparticles in a mouse model with orthotopic breast cancer. (A) Therapeutic schedule; (B) The tumor image, (C) tumor volume curves and (D) tumor weight, (E) Body weight curves; (F) Statistical analysis of body weight on the last day during treatment; (G) The ratio of the M1-like TAM (F4/80 + CD86 + ) subset; (H) The ratio of the M2-like TAM (F4/80 + CD206 + ) subset; (I) The ratio of the matured DC (CD80 + CD86 + ) subset; (J) The ratio of the PMN-MDSC (Ly6G + Ly6C − ) subset; (K) The ratio of the memory T cells (CD62L + CD44 + ) subset; (L) The ratio of the CD8 + T cells (CD3 + CD8 + ) subset; (M, N) The ratio of the cytotoxicity CD8 + T cells (IFN γ + /Granzyme B + ) subset. Data are presented as mean ± SD ( n = 3–6). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ns, not significant.

Article Snippet: MHC II antibody, CD206 antibody, CD44 antibody, CD24 antibody were purchased from Elabscience (Wuhan, China).

Techniques: In Vivo, Drug discovery